A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

Walter Reinisch; Michael Staun; Rakesh K Tandon; Istvan Altorjay; Andrew V Thillainayagam; Cornelia Gratzer; Sandeep Nijhawan; Lars Lund Thomsen

doi:10.1038/ajg.2013.335

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

Walter Reinisch, Michael Staun, Rakesh K Tandon, Istvan Altorjay, Andrew V Thillainayagam, Cornelia Gratzer, Sandeep Nijhawan, Lars Lund Thomsen

135 Citationer (Scopus)

Abstract

In the largest head-to-head comparison between an oral and an intravenous (IV) iron compound in patients with inflammatory bowel disease (IBD) so far, we strived to determine whether IV iron isomaltoside 1,000 is non-inferior to oral iron sulfate in the treatment of iron deficiency anemia (IDA).

Originalsprog	Engelsk
Tidsskrift	The American journal of gastroenterology
Vol/bind	108
Udgave nummer	12
Sider (fra-til)	1877-88
Antal sider	12
ISSN	0002-9270
DOI	https://doi.org/10.1038/ajg.2013.335
Status	Udgivet - dec. 2013

Adgang til dokumentet

10.1038/ajg.2013.335

Citationsformater

Reinisch, W., Staun, M., Tandon, R. K., Altorjay, I., Thillainayagam, A. V., Gratzer, C., Nijhawan, S., & Thomsen, L. L. (2013). A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED). The American journal of gastroenterology, 108(12), 1877-88. https://doi.org/10.1038/ajg.2013.335

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED). / Reinisch, Walter; Staun, Michael; Tandon, Rakesh K et al.
I: The American journal of gastroenterology, Bind 108, Nr. 12, 12.2013, s. 1877-88.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Reinisch, W, Staun, M, Tandon, RK, Altorjay, I, Thillainayagam, AV, Gratzer, C, Nijhawan, S & Thomsen, LL 2013, 'A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)', The American journal of gastroenterology, bind 108, nr. 12, s. 1877-88. https://doi.org/10.1038/ajg.2013.335

@article{5b1a6310d34b4b19aa20cfb4586d1fa7,

title = "A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)",

abstract = "In the largest head-to-head comparison between an oral and an intravenous (IV) iron compound in patients with inflammatory bowel disease (IBD) so far, we strived to determine whether IV iron isomaltoside 1,000 is non-inferior to oral iron sulfate in the treatment of iron deficiency anemia (IDA).",

author = "Walter Reinisch and Michael Staun and Tandon, {Rakesh K} and Istvan Altorjay and Thillainayagam, {Andrew V} and Cornelia Gratzer and Sandeep Nijhawan and Thomsen, {Lars Lund}",

year = "2013",

month = dec,

doi = "10.1038/ajg.2013.335",

language = "English",

volume = "108",

pages = "1877--88",

journal = "The American journal of gastroenterology",

issn = "0002-9270",

publisher = "Wolters Kluwer Health",

number = "12",

}

TY - JOUR

T1 - A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

AU - Reinisch, Walter

AU - Staun, Michael

AU - Tandon, Rakesh K

AU - Altorjay, Istvan

AU - Thillainayagam, Andrew V

AU - Gratzer, Cornelia

AU - Nijhawan, Sandeep

AU - Thomsen, Lars Lund

PY - 2013/12

Y1 - 2013/12

N2 - In the largest head-to-head comparison between an oral and an intravenous (IV) iron compound in patients with inflammatory bowel disease (IBD) so far, we strived to determine whether IV iron isomaltoside 1,000 is non-inferior to oral iron sulfate in the treatment of iron deficiency anemia (IDA).

AB - In the largest head-to-head comparison between an oral and an intravenous (IV) iron compound in patients with inflammatory bowel disease (IBD) so far, we strived to determine whether IV iron isomaltoside 1,000 is non-inferior to oral iron sulfate in the treatment of iron deficiency anemia (IDA).

U2 - 10.1038/ajg.2013.335

DO - 10.1038/ajg.2013.335

M3 - Journal article

C2 - 24145678

SN - 0002-9270

VL - 108

SP - 1877

EP - 1888

JO - The American journal of gastroenterology

JF - The American journal of gastroenterology

IS - 12

ER -

A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED)

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater